688293 奥浦迈
已收盘 11-20 15:00:00
资讯
新帖
简况
股市必读:奥浦迈新发布《奥浦迈:关于完成工商变更登记并换发营业执照的公告》
证券之星 · 11-16
股市必读:奥浦迈新发布《奥浦迈:关于完成工商变更登记并换发营业执照的公告》
奥浦迈(688293)披露完成工商变更登记并换发营业执照公告,11月13日股价下跌5.71%
证券之星 · 11-13
奥浦迈(688293)披露完成工商变更登记并换发营业执照公告,11月13日股价下跌5.71%
奥浦迈:11月12日召开业绩说明会,投资者参与
证券之星 · 11-13
奥浦迈:11月12日召开业绩说明会,投资者参与
11月13日奥浦迈跌5.71%,招商医药健康产业股票基金重仓该股
证券之星 · 11-13
11月13日奥浦迈跌5.71%,招商医药健康产业股票基金重仓该股
11月12日奥浦迈现7笔折价12%的大宗交易 合计成交2702.69万元
证券之星 · 11-12
11月12日奥浦迈现7笔折价12%的大宗交易 合计成交2702.69万元
股市必读:11月11日奥浦迈现1笔大宗交易 机构净买入663.8万元
证券之星 · 11-12
股市必读:11月11日奥浦迈现1笔大宗交易 机构净买入663.8万元
奥浦迈(688293)11月10日主力资金净卖出1672.00万元
证券之星 · 11-11
奥浦迈(688293)11月10日主力资金净卖出1672.00万元
11月10日奥浦迈现4笔折价12.01%的大宗交易 合计成交2403.3万元
证券之星 · 11-10
11月10日奥浦迈现4笔折价12.01%的大宗交易 合计成交2403.3万元
奥浦迈(688293)11月6日主力资金净买入561.75万元
证券之星 · 11-07
奥浦迈(688293)11月6日主力资金净买入561.75万元
11月6日奥浦迈跌5.67%,招商医药健康产业股票基金重仓该股
证券之星 · 11-06
11月6日奥浦迈跌5.67%,招商医药健康产业股票基金重仓该股
股市必读:11月5日奥浦迈现914.59万元大宗交易
证券之星 · 11-06
股市必读:11月5日奥浦迈现914.59万元大宗交易
奥浦迈:公司董事长、总经理肖志华先生毕业于纽约州立大学,获得化学工程专业博士学位
证券之星 · 11-05
奥浦迈:公司董事长、总经理肖志华先生毕业于纽约州立大学,获得化学工程专业博士学位
11月4日奥浦迈涨14.45%,招商医药健康产业股票基金重仓该股
证券之星 · 11-04
11月4日奥浦迈涨14.45%,招商医药健康产业股票基金重仓该股
奥浦迈(688293)11月3日主力资金净卖出256.18万元
证券之星 · 11-04
奥浦迈(688293)11月3日主力资金净卖出256.18万元
11月3日奥浦迈跌8.30%,招商医药健康产业股票基金重仓该股
证券之星 · 11-03
11月3日奥浦迈跌8.30%,招商医药健康产业股票基金重仓该股
股市必读:奥浦迈三季报 - 第三季度单季净利润同比下降732.80%
证券之星 · 11-02
股市必读:奥浦迈三季报 - 第三季度单季净利润同比下降732.80%
奥浦迈(688293)2026年三季报简析:增收不增利,应收账款上升
证券之星 · 11-01
奥浦迈(688293)2026年三季报简析:增收不增利,应收账款上升
奥浦迈(688293)披露2026年第三季度报告,10月30日股价下跌1.37%
证券之星 · 10-30
奥浦迈(688293)披露2026年第三季度报告,10月30日股价下跌1.37%
奥浦迈(688293)9月30日股东户数1万户,较上期增加66.2%
证券之星 · 10-30
奥浦迈(688293)9月30日股东户数1万户,较上期增加66.2%
奥浦迈(688293.SH)发布前三季度业绩,归母净利润4886.57万元,同比下降1.13%
智通财经 · 10-30
奥浦迈(688293.SH)发布前三季度业绩,归母净利润4886.57万元,同比下降1.13%
公司概况
公司名称:
上海奥浦迈生物科技股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-09-02
主营业务:
上海奥浦迈生物科技股份有限公司的主营业务是细胞培养产品与服务。公司的主要产品是细胞培养产品、CDMO服务、药物临床前CRO服务、医疗器械临床前CRO服务、实验动物销售、租赁及相关服务。截至2026年6月30日,公司拥有已授权的知识产权合计281项,其中,发明专利32项,实用新型专利100项,外观设计专利2项,软件著作权66项及其他81项。
发行价格:
80.20
{"stockData":{"symbol":"688293","market":"SH","secType":"STK","nameCN":"奥浦迈","latestPrice":58.47,"timestamp":1795158000000,"preClose":59.94,"halted":0,"volume":2792313,"delay":0,"changeRate":-0.0245,"floatShares":127000000,"shares":142000000,"eps":0.2888,"marketStatus":"已收盘","change":-1.47,"latestTime":"11-20 15:00:00","open":58,"high":60.95,"low":57.8,"amount":166000000,"amplitude":0.0526,"askPrice":58.55,"askSize":3,"bidPrice":58.47,"bidSize":17,"shortable":0,"etf":0,"ttmEps":0.2888,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795397400000},"marketStatusCode":5,"adr":0,"adjPreClose":59.94,"symbolType":"stock_kcb","openAndCloseTimeList":[[1795138200000,1795145400000],[1795150800000,1795158000000]],"highLimit":65.93,"lowLimit":53.95,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":142477399,"isCdr":false,"pbRate":2.74,"roa":"--","peRate":202.458449,"roe":"1.68%","epsLYR":0.37,"committee":-0.444444,"marketValue":8331000000,"turnoverRate":0.022,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-11-23。","afterMarket":{"amount":0,"volume":0,"close":58.47,"buyVolume":0,"sellVolume":0,"time":1795160037746,"indexStatus":"已收盘 11-20 15:30:00","preClose":59.94},"floatMarketCap":7407000000},"requestUrl":"/m/hq/s/688293/wiki","defaultTab":"wiki","newsList":[{"id":"2683123652","title":"股市必读:奥浦迈新发布《奥浦迈:关于完成工商变更登记并换发营业执照的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683123652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683123652?lang=zh_cn&edition=full","pubTime":"2026-11-16 01:23","pubTimestamp":1794763388,"startTime":"0","endTime":"0","summary":"截至2026年11月13日收盘,奥浦迈报收于64.9元,下跌5.71%,换手率4.03%,成交量5.1万手,成交额3.34亿元。当日关注点交易信息汇总:11月13日主力资金净流出2262.34万元,占总成交额6.77%。公司公告汇总:奥浦迈因实施2023年限制性股票激励计划,总股本由142,194,199股增至142,477,399股,已完成工商变更登记并换发营业执照。公司已办理完毕工商变更登记及章程备案手续,取得上海市市场监督管理局换发的营业执照。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111600000469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683492506","title":"奥浦迈(688293)披露完成工商变更登记并换发营业执照公告,11月13日股价下跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2683492506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683492506?lang=zh_cn&edition=full","pubTime":"2026-11-13 22:08","pubTimestamp":1794578902,"startTime":"0","endTime":"0","summary":"截至2026年11月13日收盘,奥浦迈报收于64.9元,较前一交易日下跌5.71%,最新总市值为92.47亿元。该股当日开盘68.57元,最高69.59元,最低63.71元,成交额达3.34亿元,换手率为4.03%。近日,奥浦迈发布《关于完成工商变更登记并换发营业执照的公告》。公告显示,因实施2023年限制性股票激励计划,公司新增股份283,200股,总股本由142,194,199股增至142,477,399股,注册资本由142,194,199元增至142,477,399元。公司已办理完毕工商变更登记及章程备案手续,取得上海市市场监督管理局换发的营业执照。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300043102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683031574","title":"奥浦迈:11月12日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2683031574","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683031574?lang=zh_cn&edition=full","pubTime":"2026-11-13 19:01","pubTimestamp":1794567689,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年11月12日奥浦迈发布公告称公司于2026年11月12日召开业绩说明会。未来在完善临床前研究、工艺开发及商业化生产能力方面,是否考虑继续通过股权投资或产业并购整合外部专业平台?境内外同行业上市公司亦较多通过并购实现业务拓展与产业链延伸。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300035983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683573252","title":"11月13日奥浦迈跌5.71%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2683573252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683573252?lang=zh_cn&edition=full","pubTime":"2026-11-13 16:45","pubTimestamp":1794559528,"startTime":"0","endTime":"0","summary":"证券之星消息,11月13日奥浦迈跌5.71%,收盘报64.9元,换手率4.03%,成交量5.1万手,成交额3.34亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共59家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300030045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682696295","title":"11月12日奥浦迈现7笔折价12%的大宗交易 合计成交2702.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682696295","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682696295?lang=zh_cn&edition=full","pubTime":"2026-11-12 17:47","pubTimestamp":1794476857,"startTime":"0","endTime":"0","summary":"证券之星消息,11月12日奥浦迈发生大宗交易,交易数据如下:近三个月该股共发生95笔大宗交易,合计成交6.02万手,折价成交95笔。该股在过去半年内已有共计1255.51万股限售解禁股上市,占公司总股本的8.81%。截至2026年11月12日收盘,奥浦迈报收于68.83元,上涨2.14%,换手率4.27%,成交量5.41万手,成交额3.75亿元。本文数据来源于上海证券交易所大宗交易信息披露,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200032043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682867775","title":"股市必读:11月11日奥浦迈现1笔大宗交易 机构净买入663.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682867775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682867775?lang=zh_cn&edition=full","pubTime":"2026-11-12 01:08","pubTimestamp":1794416893,"startTime":"0","endTime":"0","summary":"截至2026年11月11日收盘,奥浦迈报收于67.39元,上涨1.64%,换手率2.97%,成交量3.76万手,成交额2.49亿元。当日关注点交易信息汇总:11月11日主力资金净流入1333.59万元,占总成交额5.36%; 交易信息汇总:当日发生1笔大宗交易,机构净买入663.8万元。大宗交易11月11日奥浦迈发生1笔大宗交易,机构净买入663.8万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200001624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682340726","title":"奥浦迈(688293)11月10日主力资金净卖出1672.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682340726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682340726?lang=zh_cn&edition=full","pubTime":"2026-11-11 08:21","pubTimestamp":1794356464,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月10日收盘,奥浦迈报收于66.3元,上涨4.2%,换手率3.79%,成交量4.81万手,成交额3.24亿元。近5日资金流向一览见下表:奥浦迈融资融券信息显示,融资方面,当日融资买入2473.94万元,融资偿还2202.42万元,融资净买入271.51万元。奥浦迈主营业务:从事细胞培养产品与服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100013331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682393596","title":"11月10日奥浦迈现4笔折价12.01%的大宗交易 合计成交2403.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682393596","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682393596?lang=zh_cn&edition=full","pubTime":"2026-11-10 17:56","pubTimestamp":1794304594,"startTime":"0","endTime":"0","summary":"证券之星消息,11月10日奥浦迈发生大宗交易,交易数据如下:近三个月该股共发生86笔大宗交易,合计成交5.49万手,折价成交86笔。该股在过去半年内已有共计1255.51万股限售解禁股上市,占公司总股本的8.81%。截至2026年11月10日收盘,奥浦迈(688293)报收于66.3元,上涨4.2%,换手率3.79%,成交量4.81万手,成交额3.24亿元。该股近半年内有股东持股变动,合计净减持510.66万股,股东增减持明细如下表:该股最近90天内共有6家机构给出评级,买入评级4家,增持评级2家。本文数据来源于上海证券交易所大宗交易信息披露,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000036466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681813386","title":"奥浦迈(688293)11月6日主力资金净买入561.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681813386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681813386?lang=zh_cn&edition=full","pubTime":"2026-11-07 09:20","pubTimestamp":1794014417,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月6日收盘,奥浦迈报收于63.06元,下跌5.67%,换手率4.59%,成交量5.82万手,成交额3.71亿元。近5日资金流向一览见下表:奥浦迈融资融券信息显示,融资方面,当日融资买入2703.28万元,融资偿还1972.21万元,融资净买入731.07万元,连续3日净买入累计1231.4万元。奥浦迈主营业务:从事细胞培养产品与服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110700010204.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681985903","title":"11月6日奥浦迈跌5.67%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681985903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681985903?lang=zh_cn&edition=full","pubTime":"2026-11-06 17:16","pubTimestamp":1793956571,"startTime":"0","endTime":"0","summary":"证券之星消息,11月6日奥浦迈跌5.67%,收盘报63.06元,换手率4.59%,成交量5.82万手,成交额3.71亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共59家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600028805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681003387","title":"股市必读:11月5日奥浦迈现914.59万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2681003387","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681003387?lang=zh_cn&edition=full","pubTime":"2026-11-06 01:09","pubTimestamp":1793898554,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘,奥浦迈报收于66.85元,上涨2.81%,换手率5.55%,成交量7.03万手,成交额4.71亿元。当日关注点交易信息汇总:11月5日主力资金净流入1573.94万元,占总成交额3.34%; 交易信息汇总:当日发生914.59万元大宗交易; 交易信息汇总资金流向11月5日主力资金净流入1573.94万元,占总成交额3.34%;游资资金净流入554.95万元,占总成交额1.18%;散户资金净流出2128.89万元,占总成交额4.52%。大宗交易11月5日奥浦迈发生914.59万元大宗交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600001671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681049542","title":"奥浦迈:公司董事长、总经理肖志华先生毕业于纽约州立大学,获得化学工程专业博士学位","url":"https://stock-news.laohu8.com/highlight/detail?id=2681049542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681049542?lang=zh_cn&edition=full","pubTime":"2026-11-05 16:01","pubTimestamp":1793865668,"startTime":"0","endTime":"0","summary":"1997年至2000年就读于华东理工大学生物化工专业,2000年至2007年于纽约州立大学攻读博士学位。具体内容详见公司于上海证券交易所披露的相关公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500025682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680143036","title":"11月4日奥浦迈涨14.45%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680143036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680143036?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:14","pubTimestamp":1793783667,"startTime":"0","endTime":"0","summary":"证券之星消息,11月4日奥浦迈涨14.45%,收盘报65.02元,换手率5.72%,成交量7.25万手,成交额4.46亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共59家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400032230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680701706","title":"奥浦迈(688293)11月3日主力资金净卖出256.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680701706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680701706?lang=zh_cn&edition=full","pubTime":"2026-11-04 08:53","pubTimestamp":1793753632,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月3日收盘,奥浦迈报收于56.81元,下跌8.3%,换手率5.19%,成交量6.57万手,成交额3.79亿元。近5日资金流向一览见下表:奥浦迈融资融券信息显示,融资方面,当日融资买入2043.55万元,融资偿还1630.7万元,融资净买入412.85万元。奥浦迈主营业务:从事细胞培养产品与服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400011114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680745007","title":"11月3日奥浦迈跌8.30%,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680745007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680745007?lang=zh_cn&edition=full","pubTime":"2026-11-03 16:54","pubTimestamp":1793696091,"startTime":"0","endTime":"0","summary":"证券之星消息,11月3日奥浦迈跌8.30%,收盘报56.81元,换手率5.19%,成交量6.57万手,成交额3.79亿元。根据2026基金Q3季报公募基金重仓股数据,重仓该股的公募基金共59家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300033542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680207950","title":"股市必读:奥浦迈三季报 - 第三季度单季净利润同比下降732.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680207950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680207950?lang=zh_cn&edition=full","pubTime":"2026-11-02 02:45","pubTimestamp":1793558712,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年第三季度单季度归母净利润为-7516.7万元,同比下降732.8%;前三季度扣非净利润1.06亿元,同比上升183.79%。公司公告汇总奥浦迈:2026年第三季度报告上海奥浦迈生物科技股份有限公司2026年第三季度报告显示,本报告期营业收入285,054,498.44元,同比增长203.96%;年初至报告期末营业收入738,744,506.52元,同比增长172.07%。归属于上市公司股东的净利润本报告期为-75,166,973.09元,同比下降732.80%;年初至报告期末为48,865,651.30元,同比下降1.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680272363","title":"奥浦迈(688293)2026年三季报简析:增收不增利,应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2680272363","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680272363?lang=zh_cn&edition=full","pubTime":"2026-11-01 06:27","pubTimestamp":1793485659,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期奥浦迈发布2026年三季报。截至本报告期末,公司营业总收入7.39亿元,同比上升172.07%,归母净利润4886.57万元,同比下降1.13%。本报告期奥浦迈应收账款上升,应收账款同比增幅达181.82%。应收款项变动幅度为169.80%,原因:产品业务收入增长带动应收款项增加,以及子公司澎立生物纳入合并范围。持有奥浦迈最多的基金为招商医药健康产业股票,目前规模为38.0亿元,最新净值2.454,较上一交易日上涨1.28%,近一年上涨26.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110100001487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679575248","title":"奥浦迈(688293)披露2026年第三季度报告,10月30日股价下跌1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679575248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679575248?lang=zh_cn&edition=full","pubTime":"2026-10-30 22:07","pubTimestamp":1793369265,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘,奥浦迈报收于61.0元,较前一交易日下跌1.37%,最新总市值为86.91亿元。近日,上海奥浦迈生物科技股份有限公司披露《2026年第三季度报告》。公告显示,本报告期营业收入285,054,498.44元,同比增长203.96%;年初至报告期末营业收入738,744,506.52元,同比增长172.07%。归属于上市公司股东的净利润本报告期为-75,166,973.09元,同比下降732.80%;年初至报告期末为48,865,651.30元,同比下降1.13%。归属于上市公司股东的扣除非经常性损益的净利润年初至报告期末为106,049,163.13元,同比增长183.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000056655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679213865","title":"奥浦迈(688293)9月30日股东户数1万户,较上期增加66.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679213865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679213865?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:12","pubTimestamp":1793358723,"startTime":"0","endTime":"0","summary":"证券之星消息,近日奥浦迈披露,截至2026年9月30日公司股东户数为9992.0户,较6月30日增加3980.0户,增幅为66.2%。在生物制品行业个股中,奥浦迈股东户数低于行业平均水平,截至9月30日,生物制品行业平均股东户数为3.67万户。从股价来看,2026年6月30日至2026年9月30日,奥浦迈区间涨幅为91.84%,在此期间股东户数增加3980.0户,增幅为66.2%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000046580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679018294","title":"奥浦迈(688293.SH)发布前三季度业绩,归母净利润4886.57万元,同比下降1.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679018294","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679018294?lang=zh_cn&edition=full","pubTime":"2026-10-30 18:17","pubTimestamp":1793355434,"startTime":"0","endTime":"0","summary":"智通财经APP讯,奥浦迈(688293.SH)发布2026年第三季度报告,公司前三季度实现营业收入7.39亿元,同比增长172.07%;归属于上市公司股东的净利润4886.57万元,同比下降1.13%;归属于上市公司股东的扣除非经常性损益的净利润1.06亿元,同比增长183.79%;基本每股收益0.35元。前三季度,公司营业收入同比增长主要原因系奥浦迈细胞培养产品及CDMO服务业务收入增长,以及子公司澎立生物纳入合并范围所致。扣非净利润同比增长主要系营业收入稳步提升及澎立生物纳入合并范围所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1795323794304,"stockEarnings":[{"period":"1week","weight":-0.0991},{"period":"1month","weight":-0.0075},{"period":"3month","weight":-0.0498},{"period":"6month","weight":0.2912},{"period":"1year","weight":-0.0001},{"period":"ytd","weight":0.2029}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0483},{"period":"3month","weight":-0.0951},{"period":"6month","weight":-0.1408},{"period":"1year","weight":-0.1011},{"period":"ytd","weight":-0.1096}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海奥浦迈生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"9992人(较上一季度增加66.20%)","perCapita":"12678股","listingDate":"2022-09-02","address":"上海市浦东新区紫萍路908弄28号","registeredCapital":"14247万元","survey":" 上海奥浦迈生物科技股份有限公司的主营业务是细胞培养产品与服务。公司的主要产品是细胞培养产品、CDMO服务、药物临床前CRO服务、医疗器械临床前CRO服务、实验动物销售、租赁及相关服务。截至2026年6月30日,公司拥有已授权的知识产权合计281项,其中,发明专利32项,实用新型专利100项,外观设计专利2项,软件著作权66项及其他81项。","listedPrice":80.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥浦迈,688293,奥浦迈股票,奥浦迈股票老虎,奥浦迈股票老虎国际,奥浦迈行情,奥浦迈股票行情,奥浦迈股价,奥浦迈股市,奥浦迈股票价格,奥浦迈股票交易,奥浦迈股票购买,奥浦迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}